Cholecystokinin-A Receptor Messenger RNA Expression in Human Pancreatic Cancer

Journal of Gastrointestinal Surgery

Volumn 3, Issue 2, 1999, Pages 134-140

  Moonka, Ravi ^a   Zhou, Weigong ^a   Bell Jr , Richard H ^a,b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b MS 112 ^*  (United States)

Author keywords

Cholecystokinin; In situ hybridization; Pancreatic neoplasms

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ RECEPTOR; MESSENGER RNA;

ADENOCARCINOMA; ARTICLE; BIOSYNTHESIS; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IN SITU HYBRIDIZATION; METABOLISM; PANCREAS TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ADENOCARCINOMA; BLOTTING, SOUTHERN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; PANCREATIC NEOPLASMS; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033085308     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(99)80022-5     Document Type: Article

References (33)

1. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 1994;44:7-26.
2. Moonka R, Bell RH. Progress with pancreatic cancer can be obtained by focusing on these major issues. In Traverso LW, ed. Problems in General Surgery, vol 14. Philadelphia: Lippincott-Raven, 1997, pp 33-42.
3. Hildebrand P, Beglinger C, Gyr K, Jansen JB, Rovati LC, Zuercher M, Lamers CB, Setnikar I, Stalder GA. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J Clin Invest 1990;85: 640-646.
4. Povoski SP, Zhou W, Longnecker DS, Jensen RT, Mantey SA, Bell RH. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors. Gastroenterology 1994;107:1135-1146.
5. Povoski SP, Zhou W, Longnecker DS, Roebuck ED, Bell RH. Stimulation of growth of azaserine-induced putative preneoplastic lesions in the rat is mediated specifically by way of cholecystokinin-A receptors. Cancer Res 1993;53:3925-3929.
6. Howatson AG, Carter DC. Pancreatic carcinogenesis - Enhancement by cholecystokinin in the hamster-nitrosamine model. Br J Cancer 1985;51:107-114.
7. Norell SE, Ahlbom A, Erwald R, Jacobson G, Linderberg-Navier I, Olin R, Tomberg B, Wiechel KL. Diet and pancreatic cancer: A case-control study. Am J Epidemiol 1986;124: 894-902.
8. Mack TM, Yu MC, Hanisch R, Henderson BE. Pancreas cancer and smoking, beverage consumption and past medical history. J Natl Cancer Inst 1986;76:49-60.
9. Frazier ML, Pathak S, Wang Z-W, Cleary K, Singletary SE, Olive M, Mackay B, Steck PA, Levin B. Establishment of a new human pancreatic adenocarcinoma cell line. Pancreas 1990;5:8-16.
10. Funakoshi A, Kono A. Growth inhibition of human pancreatic cancer cells by cholecystokinin antagonist in tissue culture and in nude mice. Gastroenterol Jpn 1992;27:78-82.
11. Morimoto H, Nio Y, Tsubono M, Tseng C-C, Kawabata K, Masai Y, Hayashi H, Baba N, Manabe T, Hosokawa Y, Tobe T. Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505) on the growth of freshly separated and xenografted human pancreatic cancer. J Surg Oncol 1993;53:47-53.
12. Heald EB, Kramer ST, Smith JP. Trophic effects of unsulfated cholecystokinin on mouse pancreas and human pancreatic cancer. Pancreas 1992;7:530-535.
13. Smith JP, Mohesky C, Barrett B, Solomon TE. CCK stimulates growth of human pancreatic cancer. Dig Dis Sci 1986; 31:1150.
14. Smith JP, Solomon TE, Bagheri S, Kramer S. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci 1990;35:1377-1384.
15. Swift IR, Kramer ST, Smith JP. CCK stimulates growth of pancreatic cancer through a low affinity receptor [abstr]. Gastroenterology 1992;102:A944.
16. Smith JP, Rickabaugh CA, McLaughlin PJ, Zagon IS. Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. Am J Physiol 1993; 265:G149-G155.
17. Nio Y, Tsubono M, Morimoto H, Kawabata K, Masai Y, Hayashi H, Manabe T, Imamura M, Fukomoto M. Loxiglumide (CR 1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cell lines xenografted into nude mice. Cancer 1993;72:3599-3606.
18. Upp JR, Singh P, Townsend CM, Thompson JC. Predicting response to endocrine therapy in human pancreatic cancer with cholecystokinin receptors [absrr]. Gastroenterology 1987;92:1677.
19. Hudd C, LaRegina MC, Devine JE, Palmer DC, Herbold DR, Beinfield MC, Gelder FB, Johnson FE. Response to exogenous cholecystokinin of six human gastrointestinal cancers xenografted into nude mice. Am J Surg 1989;157:386-394.
20. Cantor P, Olsen O, Gertz BJ, Gjorup I, Worning H. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329. Scand J Gastroenterol 1991;26:627-637.
21. DeWeerth A, Pisegna JR, Huppi K, Wank SA. Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochem Biophys Res Commun 1993;194:811-818.
22. Weinberg DS, Ruggeri B, Barber MT, Biswas S, Miknyocki S, Waldman SA. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J Clin Invest 1997;100:597-603.
23. Upp JR, Nealon WH, Singh P, Fagan CJ, Jonas AS, Greeley GH, Thompson JC. Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones. Ann Surg 1987;205:641-648.
24. Tang C, Biemond I, Lamers CBHW. Cholecystokinin receptors in human pancreas and gallbladder muscle: A comparative study. Gastroenterology 1996;111:1621-1626.
25. Meyer BM, Beglinger C, Jansen JBMJ, Rovati LC, Werth BA, Hildebrand P, Zach D, Stalder GA. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989;2:12-15.
26. Reubi JC, Waser B, Laderach U, Stettler C, Friess H, Halter F, Schuassme. Localization of cholecystokinin A and cholecystokinin B/gastrin receptors in the human stomach. Gastroenterology 1997;112:1197-1205.
27. Soudan HC, Lu Y, Hasler WL, Owyang C. Cholecystokinin at physiologic levels evokes pancreatic enzyme secretion via a cholinergic pathway. Am J Physiol 1992;263:G102-G107.
28. Ying L, Owyang C. Vagal afferent pathway mediates physiologic action of cholecystokinin on pancreatic enzyme secretion. J Clin Invest 1993;92:418-424.
29. Susini C, Estival A, Scemama L, Ruellan C, Vaysse N, Clemente F, Esteve JP, Fourmy D, Ribet A. Studies on human pancreatic acini: Action of secretagogues on amylase release and cellular cyclic AMP accumulation. Pancreas 1986;1:124-129.
30. Tang C, Biemond I, Offerhaus GJA, Verspaget W, Lamers CBHW. Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumor-free pancreas. Br J Cancer 1997;75:1467-1473.
31. Monstein H-J, Nylander A-G, Salehi A, Chen D, Lundquist I, Hakanson R. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man: Apolymerase chain reaction study. Scand J Gastroenterol 1996;31:383-390.
32. Nishimori I, Adachi K, Kamakura M, Morita M, Onishi S, Harris A, Hollingsworth MA. Identification of the CCK-A and CCK-B receptor mRNA in adult, infant, and fetal human pancreas [abstr]. Pancreas 1997;15:449.
33. Honda T, Wada E, Battey JF, Wank SA. Differential gene expression of CCK-A and CCK-B receptors in the rat brain. Mol Cell Neurosci 1993;4:143-154.